Lanuginosine

Overview

Lanuginosine is an alkaloid. Lanuginosine can be isolated from the stems of Xylopia laevigata ( Annonaceae ) and the leaves of Magnolia grandiflora . Lanuginosine induces Apoptosis . Lanuginosine inhibits AChE ( IC 50 : 10.9 μM). Lanuginosine inhibits Aβ aggregation. Lanuginosine exhibits anticancer activity against hepatocellular carcinoma, human promyelocytic leukemia, human chronic myeloid leukemia, melanoma, and brain tumors. Lanuginosine can be used in the research of Alzheimer's disease.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Amyloid-β | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-119398
• CAS No.: 23740-25-2
• Molecular Formula: C18H11NO4
• Molecular Weight: 305.28
• Purity: 98.27%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source